Troikaa Pharmaceuticals Ltd. - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Troikaa Pharma

Based on:

M-Cap below 100cr DeciZen not available

Troikaa Pharmaceuticals Ltd. - (Amalgamated) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Troikaa Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'09Mar'10Mar'11TTM
ROCE % 14%16%15.3%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 98.8128172172
Sales YoY Gr.-29.5%34.5%-
Adj EPS 10.514.214.70
YoY Gr.-34.7%3.7%-
BVPS (₹) 55.868.382.50
Adj Net
Profit
4.45.96.10
Cash Flow from Ops. 8.76.30.2-
Debt/CF from Ops. 6.39.5500.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA34.5%
Adj EPS NANANA3.7%
BVPSNANANA20.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'09Mar'10Mar'11TTM
Return on
Equity %
15.619.216.90
Op. Profit
Mgn %
1312.59.6NAN
Net Profit
Mgn %
4.44.63.60
Debt to
Equity
21.82-
Working Cap
Days
01611660
Cash Conv.
Cycle
065770

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Troikaa Pharmaceuticals Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 172 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 30 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.3

Management X-Ray of Troikaa Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Troikaa Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Troikaa Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11
Sales98.82127.97172.08
Operating Expenses 85.99112.19155.63
Manufacturing Costs18.5723.2330.19
Material Costs25.0132.0245.36
Employee Cost 19.1523.8335.44
Other Costs 23.2733.1144.64
Operating Profit 12.8315.7816.44
Operating Profit Margin (%) 13.0%12.3%9.6%
Other Income 1.691.803.28
Interest 6.167.168.02
Depreciation 2.873.433.67
Exceptional Items 0-0.09-0.02
Profit Before Tax 5.486.928.02
Tax 1.031.201.62
Profit After Tax 4.455.726.40
PAT Margin (%) 4.5%4.5%3.7%
Adjusted EPS (₹)9.812.714.3
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11

Equity and Liabilities

Shareholders Fund 28.1333.3439.23
Share Capital 8.698.698.69
Reserves 19.4424.6530.54
Minority Interest000
Debt55.2159.7078.32
Long Term Debt55.2159.7078.32
Short Term Debt000
Trade Payables18.7325.5332.04
Others Liabilities 5.587.348.43
Total Liabilities 107.65125.90158.03

Fixed Assets

Gross Block67.8469.8275.11
Accumulated Depreciation9.1512.2515.50
Net Fixed Assets 58.6857.5759.61
CWIP 0.140.180.96
Investments 0.010.010.01
Inventories28.0343.6865.27
Trade Receivables12.9712.5415.29
Cash Equivalents 1.521.995.57
Others Assets 6.309.9211.31
Total Assets 107.65125.90158.03

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11
Cash Flow From Operating Activity 8.746.260.16
PBT 5.487.058.05
Adjustment 8.7710.5911.39
Changes in Working Capital -4.45-10.26-18.12
Tax Paid -1.06-1.11-1.17
Cash Flow From Investing Activity -14.26-2.52-6.53
Capex -14.27-2.52-6.53
Net Investments 000
Others 000
Cash Flow From Financing Activity 4.83-3.279.94
Net Proceeds from Shares 0.4300
Net Proceeds from Borrowing 05.2812.08
Interest Paid -6.16-7.16-8.02
Dividend Paid 000
Others 10.57-1.395.89
Net Cash Flow -0.690.473.58

Finance Ratio

PARTICULARSMar'09Mar'10Mar'11
Ratios
ROE (%)19.1622.1120.36
ROCE (%)14.0416.0215.28
Asset Turnover Ratio0.931.11.22
PAT to CFO Conversion(x)1.961.090.03
Working Capital Days
Receivable Days473629
Inventory Days102102114
Payable Days273252232

Troikaa Pharmaceuticals Ltd. - (Amalgamated) Stock News

Troikaa Pharmaceuticals Ltd. - (Amalgamated) FAQs

The current trading price of Troikaa Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Troikaa Pharma stood at ₹0.00.
The latest P/E ratio of Troikaa Pharma as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Troikaa Pharma as of 31-Dec-1969 is 0.00.
The 52-week high of Troikaa Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Troikaa Pharma is ₹172.1 ( Cr.) .

About Troikaa Pharmaceuticals Ltd. - (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×